A Q2 2020 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$32B

Q2 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.2B+0.0% YoY

Gross Profit

$657M53.1% margin

Operating Income

$102M8.2% margin

Net Income

$101M8.2% margin

EPS (Diluted)

$0.32

QoQ Revenue Growth

-8.8%

Cash Flow

Operating Cash Flow

$313M

Free Cash Flow

$280M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$9.5B

Total Liabilities

$4.7B

Stockholders' Equity

$4.8B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.2B	+0.0%
Gross Profit	$657M	$669M	-1.8%
Operating Income	$102M	$216M	-52.8%
Net Income	$101M	$182M	-44.5%

Revenue Segments

Life Sciences and Applied Markets

$526M42%

Agilent CrossLab

$449M36%

Diagnostics and Genomics

$263M21%

Geographic Segments

Americas

$457M37%

Asia Pacific

$447M36%

Europe

$334M27%